Street Capital Inc. specializes in producing and selling cannabis-based products in Canada. While it boasts a strong gross margin of 76.1%, its negative EBITDA and net margins indicate ongoing financial struggles, with a current ratio of 0.34 suggesting liquidity concerns. The high gross margin juxtaposed with a low market cap of $1.40M raises questions about valuation and overall financial health. Investors should weigh these strengths against the significant risks posed by its negative profitability and liquidity issues.
Loading financial metrics...
No significant red flags identified
This company appears financially healthy on available metrics
Strong gross margin of 55.3% reflects healthy unit economics.
Excellent operating cash flow margin of 20.9% indicates high-quality earnings.
Strong free cash flow margin of 20.9% provides substantial resources for dividends, buybacks, or reinvestment.
Valuation, risk assessment, competitive positioning, and key insights — all in one report.
Other Drug Manufacturers - Specialty & Generic companies of a similar size
Based on 2024-Q3 (September 30, 2024)